TPD52 and neoplasm: Furthermore, we observed that the siRNA-TPD52 transfection of CWR22Rν1 cells resulted in inhibition of tumor growth, cell migration as well as a reduction in the colony-forming ability with a marked reduction in the secretion of prostate-specific antigen (PSA) in the serum.